Moragues-Solanas, Lluis
Le-Viet, Thanh
McSorley, Elinor
Halford, Carl
Lockhart, Daniel S.
Aydin, Alp
Kay, Gemma L.
Elumogo, Ngozi
Mullen, William
O’Grady, Justin
Gilmour, Matthew W.
Funding for this research was provided by:
Medical Research Council (MR/R015937/1)
Biotechnology and Biological Sciences Research Council (BB/CCG1860/1, BB/X011011/1, BB/X011011/1, BB/R012504/1)
UK Ministry of Defence
Innovate UK (TS/S00887X/1)
Article History
Received: 17 November 2023
Accepted: 13 February 2024
First Online: 5 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: LMS has received financial support through the DART iCASE grant by Momentum Bioscience Ltd. AA, GLK and JOG are employed by Oxford Nanopore Technologies plc. and hold shares and share options in the company. EM, DSL and WM are employed by Momentum Bioscience Ltd. TLV, CH, NE and MWG have no competing interests.